European OTC Results Round-Up: Boiron, Alliance Pharma and Karo
COVID-19 had a differing impact on Q2 consumer health sales for France's Boiron, the UK's Alliance Pharma and Sweden's Karo.
You may also be interested in...
UK-based Alliance Pharma is currently looking at deals - large and small - to expand its consumer health portfolio in its existing markets, including the US and Europe.
Karo has picked up the full European rights to the Pevaryl antifungal brand from Johnson & Johnson.
Karo’s new private-equity owners have flexed their muscles to snap up Sweden’s Trimb in a move which will expand the company’s reach in the Nordics and beyond.